← Leaderboards
Matt Devalaraja
Protean Bio Inc.
$2,995,006
Attributed
$2,995,006
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $999.8K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,995,006 · 1
By mechanism
R44$2,995,006 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Engineering”
- Nancy Jean Sullivan · Boston University Medical Campus$34,500,000
- Cyrus Wadia · Activate Global, Inc.$31,489,493
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Rashada Alexander · American Association For The Advancement Of Science$22,676,040
- Jonathan H Elias · Association Of Universities For Research In Astronomy, Inc.$16,042,279
- Michael Hogarth · University Of California, San Diego$14,390,863
Research focus
EngineeringFirst-In-HumanDrug KineticsDiagnosisAcuteDoseCostClinical TrialsAdverse EffectsDesignAgonistApolipoproteins CAlanineBindingAcute PancreatitisClinical TreatmentCanis FamiliarisAcinar CellAntagonistCell InjuryAntibodiesChylomicronsClinical ChemistryFormulation
Grant awards (3)
IND-enabling studies of D6PV- a novel ApoC-II peptide mimetic therapeutic$999,776
R44 · FY2025 · DK · contact PI
Development of D6PV- a novel ApoC-II peptide mimetic therapeutic$997,746
R44 · FY2024 · DK · contact PI
Development of D6PV- a novel ApoC-II peptide mimetic therapeutic$997,484
R44 · FY2023 · DK · contact PI